Ascentage Pharma confidentially files draft registration statement for IPO of ADS on Form F-1 with SEC.
Ascentage Pharma, a US-China based pharmaceutical company, has confidentially filed a draft registration statement on Form F-1 with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) of American Depositary Shares (ADS) representing its ordinary shares. The number of shares and the price range for the proposed offering are undecided, and the IPO will proceed after the SEC completes its review process, subject to market conditions.
June 24, 2024
6 Articles